Definium Therapeutics (DFTX) Treasury Shares (2021 - 2026)

Definium Therapeutics (DFTX) has 6 years of Treasury Shares data on file, last reported at $8.2 million in Q1 2026.

• Quarterly Treasury Shares rose 37.43% year-over-year to $8.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.2 million (up 37.43% YoY) and the FY2025 annual result came in at $5.5 million, up 297.97% from the prior year.
• Treasury Shares improved to $8.2 million in Q1 2026 per DFTX's latest filing, from $5.5 million in the prior quarter.
• Across five years, Treasury Shares topped out at $14.0 million in Q1 2022 and bottomed at $792860.0 in Q1 2024.
• The 5-year median for Treasury Shares is $2.3 million (2023), against an average of $3.8 million.
• The widest annual swing landed in 2023, when Treasury Shares slumped 89.98%; it then jumped 650.3% in 2025.
• Tracing DFTX's Treasury Shares over 5 years: stood at $1.5 million in 2022, then surged by 50.3% to $2.3 million in 2023, then sank by 40.09% to $1.4 million in 2024, then surged by 297.97% to $5.5 million in 2025, then soared by 49.81% to $8.2 million in 2026.
• Per Business Quant, the three latest DFTX Treasury Shares figures stand at $8.2 million (Q1 2026), $5.5 million (Q4 2025), and $5.8 million (Q3 2025).

Peer Comparison